These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment. Jo J; Kwon KT; Ko KS J Biomed Sci; 2023 Jun; 30(1):37. PubMed ID: 37287044 [TBL] [Abstract][Full Text] [Related]
5. Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital. Thet KT; Lunha K; Srisrattakarn A; Lulitanond A; Tavichakorntrakool R; Kuwatjanakul W; Charoensri N; Chanawong A World J Microbiol Biotechnol; 2020 Jul; 36(7):102. PubMed ID: 32613355 [TBL] [Abstract][Full Text] [Related]
6. Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates. Srinivas P; Hunt LN; Pouch SM; Thomas K; Goff DA; Pancholi P; Balada-Llasat JM; Bauer KA Diagn Microbiol Infect Dis; 2018 Jun; 91(2):194-198. PubMed ID: 29482871 [TBL] [Abstract][Full Text] [Related]
7. [Comparative evaluation of the sensitivity of Acinetobacter to colistin, using the prediffusion and minimum inhibitory concentration methods: detection of heteroresistant isolates]. Herrera ME; Mobilia LN; Posse GR Rev Argent Microbiol; 2011; 43(2):115-9. PubMed ID: 21731974 [TBL] [Abstract][Full Text] [Related]
8. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. Cai Y; Chai D; Wang R; Liang B; Bai N J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575 [TBL] [Abstract][Full Text] [Related]
9. Resistance and heteroresistance to colistin among clinical isolates of Acinetobacter baumannii. Çağlan E; Nigiz Ş; Sancak B; Gür D Acta Microbiol Immunol Hung; 2020 Jun; 67(2):107-111. PubMed ID: 31813259 [TBL] [Abstract][Full Text] [Related]
10. Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China. Chen L; Lin J; Lu H; Zhang X; Wang C; Liu H; Zhang X; Li J; Cao J; Zhou T J Antibiot (Tokyo); 2020 Jul; 73(7):463-470. PubMed ID: 32152526 [TBL] [Abstract][Full Text] [Related]
11. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Li J; Rayner CR; Nation RL; Owen RJ; Spelman D; Tan KE; Liolios L Antimicrob Agents Chemother; 2006 Sep; 50(9):2946-50. PubMed ID: 16940086 [TBL] [Abstract][Full Text] [Related]
12. Emergence of colistin and carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (CCR-Acb) complex in a neurological intensive care unit followed by successful control of the outbreak. Metan G; Zarakolu P; Otlu B; Tekin İ; Aytaç H; Bölek EÇ; Metin BC; Arsava EM; Ünal S J Infect Public Health; 2020 Apr; 13(4):564-570. PubMed ID: 31672426 [TBL] [Abstract][Full Text] [Related]
13. High rate of colistin dependence in Acinetobacter baumannii. Hong YK; Lee JY; Wi YM; Ko KS J Antimicrob Chemother; 2016 Aug; 71(8):2346-8. PubMed ID: 27076109 [No Abstract] [Full Text] [Related]
14. Two types of colistin heteroresistance in Hong YK; Kim H; Ko KS Emerg Microbes Infect; 2020 Dec; 9(1):2114-2123. PubMed ID: 32897166 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii. Kon H; Hameir A; Nutman A; Temkin E; Keren Paz A; Lellouche J; Schwartz D; Weiss DS; Kaye KS; Daikos GL; Skiada A; Durante-Mangoni E; Dishon Benattar Y; Yahav D; Daitch V; Bernardo M; Iossa D; Friberg LE; Theuretzbacher U; Leibovici L; Dickstein Y; Pollak D; Mendelsohn S; Paul M; Carmeli Y Microbiol Spectr; 2023 Jun; 11(3):e0509322. PubMed ID: 37219426 [TBL] [Abstract][Full Text] [Related]
16. Characterization of Miller AA; Moussa SH; McLeod SM Antimicrob Agents Chemother; 2024 May; 68(5):e0169823. PubMed ID: 38567976 [No Abstract] [Full Text] [Related]
17. Discrepancies in susceptibility testing to colistin in Acinetobacter baumannii: The influence of slow growth and heteroresistance. Rodriguez CH; Traglia G; Bastias N; Pandolfo C; Bruni G; Nastro M; Barrios R; Bavastro EM; Rey MC; Marques IA; Heger F; Vay C; Fernandez JS; Ramirez MS; Famiglietti A Int J Antimicrob Agents; 2019 Nov; 54(5):587-591. PubMed ID: 31400469 [TBL] [Abstract][Full Text] [Related]
18. Contribution of efflux to colistin heteroresistance in a multidrug resistant Acinetobacter baumannii clinical isolate. Machado D; Antunes J; Simões A; Perdigão J; Couto I; McCusker M; Martins M; Portugal I; Pacheco T; Batista J; Toscano C; Viveiros M J Med Microbiol; 2018 Jun; 67(6):740-749. PubMed ID: 29717972 [TBL] [Abstract][Full Text] [Related]
19. Variation in formation of persister cells against colistin in Acinetobacter baumannii isolates and its relationship with treatment failure. Chung ES; Wi YM; Ko KS J Antimicrob Chemother; 2017 Jul; 72(7):2133-2135. PubMed ID: 28379382 [No Abstract] [Full Text] [Related]